Didem Saygin to Myositis
This is a "connection" page, showing publications Didem Saygin has written about Myositis.
Connection Strength
10.859
-
Current myositis clinical trials and tribulations. Ann Rheum Dis. 2024 Jun 12; 83(7):826-829.
Score: 0.915
-
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review. Clin Exp Rheumatol. 2024 Feb; 42(2):403-412.
Score: 0.897
-
Serum cytokine profiles of adults with idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2024 Feb; 42(2):229-236.
Score: 0.887
-
Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group. Semin Arthritis Rheum. 2024 Feb; 64:152339.
Score: 0.883
-
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023 Nov 02; 62(11):3672-3679.
Score: 0.877
-
Consumer-based activity trackers in evaluation of physical activity in myositis patients. Rheumatology (Oxford). 2022 Jul 06; 61(7):2951-2958.
Score: 0.800
-
Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy. J Clin Rheumatol. 2022 Oct 01; 28(7):367-373.
Score: 0.796
-
Glucocorticoids in Myositis: Initiation, Tapering, and Discontinuation. Curr Rheumatol Rep. 2022 Mar; 24(3):47-53.
Score: 0.782
-
Assessment of Physical Activity and Muscle Function in Adult Inflammatory Myopathies. Curr Rheumatol Rep. 2022 Mar; 24(3):54-63.
Score: 0.781
-
Hand-held dynamometry for assessment of muscle strength in patients with inflammatory myopathies. Rheumatology (Oxford). 2021 May 14; 60(5):2146-2156.
Score: 0.739
-
Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy. Semin Arthritis Rheum. 2021 Jun; 51(3):539-546.
Score: 0.735
-
Follow-up results of myositis patients treated with H. P. Acthar gel. Rheumatology (Oxford). 2020 Oct 01; 59(10):2976-2981.
Score: 0.708
-
Collaborative research in myositis-related disorders: MIHRA, a global shared community model. Clin Exp Rheumatol. 2024 Feb; 42(2):207-212.
Score: 0.224
-
Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathy. Rheumatology (Oxford). 2023 Dec 01; 62(12):3957-3961.
Score: 0.220
-
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023 Nov 02; 62(11):3680-3689.
Score: 0.219
-
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group. Semin Arthritis Rheum. 2023 Feb; 58:152111.
Score: 0.205
-
Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy. Rheumatology (Oxford). 2021 Dec 01; 60(12):5713-5723.
Score: 0.192